Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
Abstract Programmed death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) help tumor cells evade immune surveillance, and are regarded as important targets of anti-tumor immunotherapy. Post-translational modification of PD-L1 has potential value in immunosuppression. Here, we identified th...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
语言: | 英语 |
出版: |
2022
|
在线阅读: | https://doi.org/10.1038/s41418-022-01102-z https://www.nature.com/articles/s41418-022-01102-z.pdf |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|